Innopharmascreen
Incheon
About Innopharmascreen
Innopharmascreen develops a protein chip-based, AI-aided drug discovery platform built to find novel drugs for a selected target. The company focuses on assisting in novel drug discovery through its technology, which is based on a protein-protein interaction assay system and an antibody microarray-based mode of action, helping pharmaceutical and biotechnology companies discover new drugs.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $5.0M
- Funding stage: Early Stage Venture
- Last round: Series A (Dec 2020)
- Website: innopharmascreen.com
- Phone: +82-(0)32-834-8321
Industries & Categories
Biotechnology, Pharmaceutical
Canonical: https://fsome.com/organization/innopharmascreen-106965 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.